Hydroquinone 4%, Tretinoin 0.05%, Fluocinolone Acetonide 0.01%: A Safe and Efficacious 12-Month Treatment for MelasmaJanuary 1, 2005Pigmentation Disorders
A Microsponge Formulation of Hydroquinone 4% and Retinol 0.15% in the Treatment of Melasma and Postinflammatory HyperpigmentationDecember 1, 2004Pigmentation Disorders
Hyperpigmented Scar Due to Minocycline TherapyNovember 1, 2004Contact DermatitisPigmentation Disorders
Mequinol 2%/Tretinoin 0.01% Solution: An Effective and Safe Alternative to Hydroquinone 3% in the Treatment of Solar LentiginesNovember 1, 2004Aesthetic DermatologyPigmentation Disorders
Over-the-Counter Topical Skin Products—A Common Component of Skin Disease ManagementJuly 1, 2004AcneAesthetic DermatologyContact DermatitisInfectious DiseasesPigmentation DisordersPsoriasisRosacea
Evaluation of Inherent Differences Between African American and White Skin Surface Properties Using Subjective and Objective MeasuresJune 1, 2004Pigmentation Disorders
A Double-Blind Comparative Study of Sodium Sulfacetamide Lotion 10% Versus Selenium Sulfide Lotion 2.5% in the Treatment of Pityriasis (Tinea) VersicolorJune 1, 2004Infectious DiseasesPigmentation Disorders
Large Solitary Café au Lait Spots: A Report of 5 Cases and Review of the LiteratureMay 1, 2004Pigmentation Disorders
Cutaneous Laser Surgery in Darker Skin PhototypesJanuary 1, 2004Aesthetic DermatologyPigmentation Disorders
Epidemiology of Skin Diseases in People of ColorApril 1, 2003AcneNonmelanoma Skin CancerContact DermatitisPigmentation DisordersPsoriasisUrticaria
